Oncogenic Signalling Networks and Polypharmacology as Paradigms to Cope with Cancer Heterogeneity

E-ISSN： 1875-6247|11|3|210-217

ISSN： 1570-1646

Source： Current Proteomics, Vol.11, Iss.3, 2014-10, pp. : 210-217

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Signalling networks that cause cancer

By McCormick F.

Trends in Biochemical Sciences, Vol. 24, Iss. 12, 1999-12 ,pp. : 53-56

Elsevier

Access to resources Recommend Favorite

Signalling networks that cause cancer

By McCormick F.

Trends in Cell Biology, Vol. 9, Iss. 12, 1999-12 ,pp. : 53-56

Elsevier

Access to resources Recommend Favorite

High-mobility group A1 proteins enhance the expression of the oncogenic miR-222 in lung cancer cells

By Zhang Yunzhi Ma Teng Yang Shuping Xia Mingying Xu Jing An Haijia Yang Yajun Li Shilin

Molecular and Cellular Biochemistry, Vol. 357, Iss. 1-2, 2011-11 ,pp. : 363-371

Springer Publishing Company

Access to resources Recommend Favorite

Inhibiting the TGF-β signalling pathway as a means of cancer immunotherapy

By Kirkbride Kellye C Blobe Gerard C

Expert Opinion on Biological Therapy, Vol. 3, Iss. 2, 2003-04 ,pp. : 251-261

Informa Healthcare

Access to resources Recommend Favorite

Mammary Stem Cells and Breast Cancer—Role of Notch Signalling

By Farnie Gillian Clarke Robert

Stem Cell Reviews, Vol. 3, Iss. 2, 2007-06 ,pp. : 169-175

Humana Press, Inc

Access to resources Recommend Favorite